Kostiukova, N. et al. 2023. CYP2C19*2 gene variant (G681A, rs4244285) as a prognostic marker for the clinical course of multiple myeloma. Experimental Oncology. 43, 4 (May 2023), 336–340. DOI:https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-4.16924.